Institute of Computational Comparative Medicine, Kansas State University, Manhattan, Kansas, USA.
Department of Anatomy and Physiology, Kansas State University, Manhattan, Kansas, USA.
Appl Environ Microbiol. 2018 Apr 16;84(9). doi: 10.1128/AEM.02724-17. Print 2018 May 1.
To assess phenotypic bacterial antimicrobial resistance (AMR) in different strata (e.g., host populations, environmental areas, manure, or sewage effluents) for epidemiological purposes, isolates of target bacteria can be obtained from a stratum using various sample types. Also, different sample processing methods can be applied. The MIC of each target antimicrobial drug for each isolate is measured. Statistical equivalence testing of the MIC data for the isolates allows evaluation of whether different sample types or sample processing methods yield equivalent estimates of the bacterial antimicrobial susceptibility in the stratum. We demonstrate this approach on the antimicrobial susceptibility estimates for (i) nontyphoidal spp. from ground or trimmed meat versus cecal content samples of cattle in processing plants in 2013-2014 and (ii) nontyphoidal spp. from urine, fecal, and blood human samples in 2015 (U.S. National Antimicrobial Resistance Monitoring System data). We found that the sample types for cattle yielded nonequivalent susceptibility estimates for several antimicrobial drug classes and thus may gauge distinct subpopulations of salmonellae. The quinolone and fluoroquinolone susceptibility estimates for nontyphoidal salmonellae from human blood are nonequivalent to those from urine or feces, conjecturally due to the fluoroquinolone (ciprofloxacin) use to treat infections caused by nontyphoidal salmonellae. We also demonstrate statistical equivalence testing for comparing sample processing methods for fecal samples (culturing one versus multiple aliquots per sample) to assess AMR in fecal These methods yield equivalent results, except for tetracyclines. Importantly, statistical equivalence testing provides the MIC difference at which the data from two sample types or sample processing methods differ statistically. Data users (e.g., microbiologists and epidemiologists) may then interpret practical relevance of the difference. Bacterial antimicrobial resistance (AMR) needs to be assessed in different populations or strata for the purposes of surveillance and determination of the efficacy of interventions to halt AMR dissemination. To assess phenotypic antimicrobial susceptibility, isolates of target bacteria can be obtained from a stratum using different sample types or employing different sample processing methods in the laboratory. The MIC of each target antimicrobial drug for each of the isolates is measured, yielding the MIC distribution across the isolates from each sample type or sample processing method. We describe statistical equivalence testing for the MIC data for evaluating whether two sample types or sample processing methods yield equivalent estimates of the bacterial phenotypic antimicrobial susceptibility in the stratum. This includes estimating the MIC difference at which the data from the two approaches differ statistically. Data users (e.g., microbiologists, epidemiologists, and public health professionals) can then interpret whether that present difference is practically relevant.
为了评估不同层次(例如宿主群体、环境区域、粪便或污水废水等)的表型细菌对抗微生物药物的耐药性(AMR),可以使用各种样本类型从某一层次中获取目标细菌的分离株。也可以应用不同的样本处理方法。测量每个目标抗菌药物对每个分离株的最小抑菌浓度(MIC)。对分离株的 MIC 数据进行统计学等效性检验,可以评估不同的样本类型或样本处理方法是否能对该层次的细菌对抗微生物药物敏感性得出等效的估计。我们以 2013-2014 年加工工厂中来自地面或修剪肉的非伤寒沙门氏菌与盲肠内容物样本,以及 2015 年来自尿液、粪便和血液的人类非伤寒沙门氏菌样本(美国国家抗微生物药物耐药性监测系统数据)为例,演示了这种方法。我们发现,牛的样本类型对某些抗菌药物类别产生了不一致的敏感性估计,因此可能衡量了沙门氏菌的不同亚群。人类血液中非伤寒沙门氏菌的喹诺酮类和氟喹诺酮类药物敏感性估计与尿液或粪便中的估计值不一致,推测是由于氟喹诺酮类药物(环丙沙星)用于治疗非伤寒沙门氏菌引起的感染。我们还演示了用于比较粪便样本处理方法(每个样本一个或多个等分试样的培养)的统计等效性检验,以评估粪便中沙门氏菌的 AMR。这些方法除了四环素类药物外,结果都是等效的。重要的是,统计等效性检验提供了数据来自两种样本类型或样本处理方法的 MIC 差异,该差异在统计学上存在差异。数据使用者(例如微生物学家和流行病学家)可以根据实际意义解释差异。需要对不同人群或层次进行细菌抗微生物药物耐药性(AMR)评估,以便进行监测和确定干预措施阻止 AMR 传播的效果。为了评估表型抗微生物药物敏感性,可以使用不同的样本类型从某一层次中获得目标细菌的分离株,或者在实验室中采用不同的样本处理方法。测量每个目标抗菌药物对每个分离株的 MIC,得到每个样本类型或样本处理方法的分离株的 MIC 分布。我们描述了 MIC 数据的统计等效性检验,用于评估两种样本类型或样本处理方法是否能对该层次的细菌表型抗微生物药物敏感性得出等效的估计。这包括估计数据来自两种方法的 MIC 差异,在统计学上存在差异。数据使用者(例如微生物学家、流行病学家和公共卫生专业人员)可以解释该差异在实际中是否具有重要意义。